acecainide has been researched along with Nervous System Disorders in 1 studies
Acecainide: A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.
N-acetylprocainamide : A benzamide obtained via formal condensation of 4-acetamidobenzoic acid and 2-(diethylamino)ethylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy, plasma drug concentrations and adverse effects of a new sustained release preparation of procainamide, 33 patients with heart disease were studied in an acute dose-ranging protocol and a chronic treatment protocol." | 1.26 | Efficacy, plasma concentrations and adverse effects of a new sustained release procainamide preparation. ( Bigger, JT; Fenster, PE; Giardina, EG; Marcus, FI; Mayersohn, M; Perrier, D, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giardina, EG | 1 |
| Fenster, PE | 1 |
| Bigger, JT | 1 |
| Mayersohn, M | 1 |
| Perrier, D | 1 |
| Marcus, FI | 1 |
1 other study available for acecainide and Nervous System Disorders
| Article | Year |
|---|---|
Efficacy, plasma concentrations and adverse effects of a new sustained release procainamide preparation.
Topics: Acecainide; Acetylation; Adult; Aged; Anti-Arrhythmia Agents; Antibodies, Antinuclear; Arrhythmias, | 1980 |